Elevance Health, Inc. - ELV STOCK NEWS

Elevance Health (NYSE: ELV) will present at the 4th Annual Wolfe Research Healthcare Conference in New York City on November 16 at 10:00 a.m. EST. Stakeholders can access the live webcast by visiting Elevance Health’s website. A replay will be available for 90 days post-presentation. Elevance Health is dedicated to enhancing healthcare access for over 119 million individuals through its comprehensive portfolio of medical, digital, and behavioral health solutions.

The recent study commissioned by Elevance Health reveals that 94% of Americans who used virtual primary care are satisfied, with 79% feeling empowered about their health. Conducted by The Harris Poll, the survey of over 5,000 adults shows that convenience and accessibility are key attractions to virtual care. While 48% are familiar with the term, 73% find it appealing. Many Americans, especially those with chronic conditions, see it as a way to enhance healthcare access. The study confirms a significant rise in telehealth usage, nearly 20 times pre-pandemic levels.

Elevance Health (NYSE: ELV) will present at the 31st Annual Credit Suisse Healthcare Conference on November 9, at 11:35 a.m. PST in Rancho Palos Verdes, California. Interested individuals can access the live webcast via www.elevancehealth.com. A replay will be available for 90 days after the presentation. Elevance Health serves over 119 million people with a range of healthcare solutions, dedicated to improving health outcomes and supporting communities.

The Board of Directors of Elevance Health (NYSE: ELV) announced the appointment of Deanna Strable to the Board. With over 30 years in financial services, Strable is currently CFO of Principal Financial Group, responsible for financial integrity and growth. Her experience includes leading the U.S. Insurance Solutions division. Strable's appointment brings the board's female and diverse director representation to over 70%. Elizabeth Tallett, Board Chair, highlighted her proven expertise in the insurance sector and commitment to diversity.

Elevance Health reported strong third quarter 2022 results with a GAAP net income of $6.68 per share, adjusted net income at $7.53 per share, and operating revenue of $39.6 billion, up 11.5% year-over-year. Medical enrollment increased by 2.2 million to 47.3 million members. The company also declared a fourth quarter dividend of $1.28 per share. With a projected full-year GAAP net income exceeding $25.33 per share, Elevance demonstrates robust growth driven by strategic operations and increasing membership.

Elevance Health announced its affiliated health plans will offer $0 premium Medicare Advantage plans targeting nearly 33 million Medicare-eligible individuals. With inflation impacting costs, three-quarters of their plans for 2023 feature zero premiums and no co-pays for primary care visits. A new prepaid benefits card simplifies access to various benefits. Additionally, eligible consumers can receive grocery card benefits and access to dietitians. The plans will expand to serve 2.1 million new Medicare-eligible consumers across 145 counties, bolstering Elevance Health's presence in the Medicare market.

Elevance Health has announced that its affiliated Medicare Advantage plans received an overall 4 out of 5 Star rating from the Centers for Medicare & Medicaid Services (CMS) for 2023. Notably, 64% of beneficiaries will enroll in plans rated 4 Stars or higher. Some plans, including HealthSun Health Plans and Optimum Healthcare, achieved the maximum 5 Star rating for multiple years. This success is attributed to improved consumer experiences and a focus on digital innovations aimed at enhancing health outcomes.

Elevance Health (NYSE: ELV) will announce its third-quarter 2022 financial results on October 19, 2022, at 6:00 a.m. EDT. A conference call will follow at 8:30 a.m. EDT, accessible by dialing the provided numbers. The access code for the call is 3972058. A replay will be available from 11:30 a.m. EDT on the same day until November 18, 2022. Elevance Health serves over 118 million consumers with a diverse range of health solutions, aiming to enhance human health.

Elevance Health announces substantial financial support for recovery efforts in the wake of Hurricane Ian. The company is donating a total of $2.7 million to various disaster relief organizations to assist Florida and other affected communities. Key contributions include $1 million each to the Florida Disaster Relief fund and the American Red Cross, along with additional funding to Americares, Direct Relief, and Rebuilding Together. These initiatives aim to provide critical medical supplies and support to over 1 million members of affiliated health plans.